-
Needham & Company LLC Reaffirms Buy Rating for Stoke Therapeutics (NASDAQ:STOK)
来源: Buzz FX / 08 1月 2025 08:26:15 America/New_York
Needham & Company LLC Reaffirms Buy Rating for Stoke Therapeutics (NASDAQ:STOK) Written by MarketBeat January 8, 2025 Share Link copied to clipboard. Stoke Therapeutics ( NASDAQ:STOK - Get Free Report ) 's stock had its "buy" rating restate
Read more...